Benzinga | Nov 5, 2020 12:26PM EST

Canaccord Genuity Maintains Buy on T2 Biosystems, Lowers Price Target to $3.5

Canaccord Genuity maintains T2 Biosystems (NASDAQ:TTOO) with a Buy and lowers the price target from $4 to $3.5.